Retinal Disease
117
24
28
49
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
17 trials with published results (15%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.0%
14 terminated out of 117 trials
77.8%
-8.7% vs benchmark
9%
10 trials in Phase 3/4
35%
17 of 49 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 49 completed trials
Clinical Trials (117)
Defining Retinal and Choroidal Structures Using Hyperspectral Imaging
Peripheral Retina Robotically Aligned OCT Study
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
Cell Collection to Study Eye Diseases
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
National Eye Institute Biorepository for Retinal Diseases
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
Advancing Pediatric Retinal Imaging With Auto-aligned OCT
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients
A Multimodal AI Agent for Ophthalmic Clinical Decision Support
Data Gathering for A10900
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services
CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum
Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001
Intraoperative OCT Guidance of Intraocular Surgery II
Optimize Pediatric OCT Imaging